To the editor,Diagnosis of sinusoidal obstruction syndrome (SOS) after hematopoietic cell transplantation (HCT) is based on clinical criteria including weight gain, ascites, he-patomegaly, and jaundice.[1] However, clinical and histological features and prognosis of SOS after liver transplantation (LT) seem ...
-
November 15, 2022 (v1)PublicationUploaded on: March 24, 2023
-
February 27, 2015 (v1)Publication
No description
Uploaded on: March 27, 2023 -
February 27, 2015 (v1)Publication
No description
Uploaded on: March 27, 2023 -
May 24, 2023 (v1)Publication
Livers from donation after circulatory death (DCD) donors are an increasingly more common source of organs for transplantation. While there are few high-level studies in the field of DCD liver transplantation, clinical practice has undergone progressive changes during the past decade, in particular due to mounting use of postmortem normothermic...
Uploaded on: May 26, 2023 -
February 27, 2015 (v1)Publication
No description
Uploaded on: March 27, 2023 -
April 29, 2020 (v1)Publication
Despite the development of new antineoplastic agents for the treatment of colorectal cancer (CRC), oxaliplatin and fluoropyrimidines remain the most commonly employed drugs for the treatment of both early and advanced disease. Intrinsic or acquired resistance is, however, an important limitation to pharmacological therapy, and the development...
Uploaded on: December 4, 2022 -
April 30, 2020 (v1)Publication
Orthotopic liver transplantation (OLT) is the recommended treatment for patients at early stages of hepatocarcinoma (HCC) with potential portal hypertension and/or bilirubinemia, but without vascular-associated diseases. The patients are receiving immunosuppressive therapy to reduce graft rejection, but differential side effects have been...
Uploaded on: March 25, 2023 -
June 10, 2020 (v1)Publication
Background/Aims: Orthotopic liver transplantation (OLT) is the recommended treatment for patients at early stages of hepatocarcinoma (HCC) with portal hypertension and/or increased bilirubinemia, but without vascular-associated diseases. Tumor recurrence, which is the main drawback for the survival of patients submitted to OLT for HCC, has...
Uploaded on: December 4, 2022 -
September 21, 2022 (v1)Publication
Background: Effective biomarkers are needed to enable personalized medicine for pancreatic cancer patients. This study analyzes the prognostic value, in early pancreatic cancer, of single circulating tumor cell (CTC) and CTC clusters from the central venous catheter (CVC) and portal blood (PV). Methods: In total, 7 mL of PV and CVC blood from...
Uploaded on: March 24, 2023